These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 8900430)
1. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Degeorges A; Tatoud R; Fauvel-Lafeve F; Podgorniak MP; Millot G; de Cremoux P; Calvo F Int J Cancer; 1996 Oct; 68(2):207-14. PubMed ID: 8900430 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Okamoto M; Lee C; Oyasu R Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055 [TBL] [Abstract][Full Text] [Related]
3. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Sakko AJ; Ricciardelli C; Mayne K; Tilley WD; Lebaron RG; Horsfall DJ Cancer Res; 2001 Feb; 61(3):926-30. PubMed ID: 11221884 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of antiproliferative effects of interleukin-1beta and tumor necrosis factor-alpha on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6. Kawada M; Ishizuka M; Takeuchi T Jpn J Cancer Res; 1999 May; 90(5):546-54. PubMed ID: 10391095 [TBL] [Abstract][Full Text] [Related]
7. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Giri D; Ittmann M Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462 [TBL] [Abstract][Full Text] [Related]
9. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851 [TBL] [Abstract][Full Text] [Related]
10. Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness. Minamiguchi K; Kawada M; Someno T; Ishizuka M Biochem Biophys Res Commun; 2003 Jul; 306(3):629-36. PubMed ID: 12810065 [TBL] [Abstract][Full Text] [Related]
11. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665 [TBL] [Abstract][Full Text] [Related]
12. Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system. Iacopino F; Angelucci C; Sica G Anticancer Res; 2012 May; 32(5):1579-88. PubMed ID: 22593435 [TBL] [Abstract][Full Text] [Related]
13. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia]. Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609 [TBL] [Abstract][Full Text] [Related]
14. Stromal cells of the human prostate: initial isolation and characterization. Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397 [TBL] [Abstract][Full Text] [Related]
15. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Lang SH; Stower M; Maitland NJ Br J Cancer; 2000 Feb; 82(4):990-7. PubMed ID: 10732776 [TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
17. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction]. Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208 [TBL] [Abstract][Full Text] [Related]
18. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels. Hall JA; Maitland NJ; Stower M; Lang SH Cancer Res; 2002 Jan; 62(1):58-62. PubMed ID: 11782359 [TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Das S; Roth CP; Wasson LM; Vishwanatha JK Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178 [TBL] [Abstract][Full Text] [Related]
20. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta. Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]